Kangmei Pharmaceutical Co., Ltd. (SHA: 600518)

Kangmei Pharmaceutical Revenue

Kangmei Pharmaceutical had revenue of 1.40B CNY in the quarter ending September 30, 2024, with 20.92% growth. This brings the company's revenue in the last twelve months to 5.21B, up 4.43% year-over-year. In the year 2023, Kangmei Pharmaceutical had annual revenue of 4.87B with 16.60% growth.

• Revenue (ttm): 5.21B
• Revenue Growth: +4.43%
• P/S Ratio: 6.70
• Revenue / Employee: 1.18M
• Employees: 4,409
• Market Cap: 34.94B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	4.87B	693.87M	16.60%
Dec 31, 2022	4.18B	27.63M	0.67%
Dec 31, 2021	4.15B	-1.26B	-23.27%
Dec 31, 2020	5.41B	-6.03B	-52.72%
Dec 31, 2019	11.45B	-5.62B	-32.93%